DK1347778T3 - Adfærdskemoterapi - Google Patents

Adfærdskemoterapi

Info

Publication number
DK1347778T3
DK1347778T3 DK00980907T DK00980907T DK1347778T3 DK 1347778 T3 DK1347778 T3 DK 1347778T3 DK 00980907 T DK00980907 T DK 00980907T DK 00980907 T DK00980907 T DK 00980907T DK 1347778 T3 DK1347778 T3 DK 1347778T3
Authority
DK
Denmark
Prior art keywords
protocol
stimulation
continuing
behavioral
chemotherapy
Prior art date
Application number
DK00980907T
Other languages
English (en)
Inventor
Mark H Eig
Original Assignee
Be Able Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Be Able Llc filed Critical Be Able Llc
Application granted granted Critical
Publication of DK1347778T3 publication Critical patent/DK1347778T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Seasonings (AREA)
  • Electrotherapy Devices (AREA)
DK00980907T 2000-12-01 2000-12-01 Adfærdskemoterapi DK1347778T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/032697 WO2002043764A1 (en) 2000-12-01 2000-12-01 Behavior chemotherapy

Publications (1)

Publication Number Publication Date
DK1347778T3 true DK1347778T3 (da) 2006-10-09

Family

ID=21742043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00980907T DK1347778T3 (da) 2000-12-01 2000-12-01 Adfærdskemoterapi

Country Status (12)

Country Link
EP (1) EP1347778B1 (da)
JP (1) JP2004525867A (da)
CN (1) CN100457182C (da)
AT (1) ATE329620T1 (da)
AU (2) AU2001218105B2 (da)
CA (1) CA2429801A1 (da)
DE (1) DE60028841T2 (da)
DK (1) DK1347778T3 (da)
ES (1) ES2266008T3 (da)
MX (1) MXPA03004765A (da)
PT (1) PT1347778E (da)
WO (1) WO2002043764A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617361B2 (en) * 1999-11-05 2003-09-09 Be Able, Llc Behavior chemotherapy
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
FR2926221A1 (fr) * 2008-01-14 2009-07-17 Tassin Thomas Compositions permettant la reproduction artificielle des conditions pharmacologiques de la dependance aux drogues addictives telles que opiaces, psychostimulants, tabac et alcool, par la combinaison de nicotine et d'un ligand.
EP2608794A4 (en) * 2010-08-26 2014-01-22 Univ Northeastern METHOD AND COMPOSITIONS FOR PREVENTING OR TREATING OIL CONTAINER
CN105303031B (zh) * 2015-09-21 2018-02-27 中国科学技术馆 一种内隐记忆测试方法及系统
WO2024105423A1 (en) * 2022-11-17 2024-05-23 Sorbonne Universite A dosage regimen using low doses of donepezil or derivative thereof for preventing or treating a compulsive disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010020422A (ko) * 1997-04-29 2001-03-15 케니쓰 블럼, 인코포레이티드 보상 결핍 증후군의 대립형질 폴리유전자 진단 및 치료

Also Published As

Publication number Publication date
AU2001218105B2 (en) 2005-10-06
AU1810501A (en) 2002-06-11
WO2002043764A1 (en) 2002-06-06
CA2429801A1 (en) 2002-06-06
EP1347778A1 (en) 2003-10-01
DE60028841T2 (de) 2006-12-28
CN1461222A (zh) 2003-12-10
EP1347778B1 (en) 2006-06-14
MXPA03004765A (es) 2005-02-14
PT1347778E (pt) 2006-08-31
CN100457182C (zh) 2009-02-04
HK1059399A1 (en) 2004-07-02
JP2004525867A (ja) 2004-08-26
ATE329620T1 (de) 2006-07-15
ES2266008T3 (es) 2007-03-01
DE60028841D1 (de) 2006-07-27

Similar Documents

Publication Publication Date Title
PL397846A1 (pl) Leczenie zaburzeń związanych z TNFα
DE60225822D1 (de) Vorrichtung zur verabreichung von medikamenten durch intraokulare iontophorese oder electroporation
EA199900620A1 (ru) Фталазиноны
MXPA02007099A (es) Compuestos de tiazola, imidazola y oxazola y tratamientos de desordenes asociados con la maduracion de la proteina.
AR028705A1 (es) Bis-arilsulfonas
NO20032027L (no) Effektive antitumorbehandlinger
CY1111946T1 (el) To (1s, 5s) -3-(5,6-διχλωρο-3-πυριδινυλο)-3, 6-διαζαδικυ-κλο[3.2.0]επτανιο ειναι ενας αποτελεσματiκος αναλγητικος παραγοντας
WO2004082624A3 (en) Modafinil-based neurorehabilitation of impaired neurological function associated with injury
DK1347778T3 (da) Adfærdskemoterapi
ATE402734T1 (de) Programmiergerät für medizinisches gerät mit infrarot-kommunikation
MXPA04004455A (es) Quimioterapia de balance de neurotransmisor.
HRP20040383B1 (hr) Ne-neurotoksični faktori aktivacije plazminogena za liječenje moždanog udara
TW200505437A (en) Composition possessing autonomic nerve function regulating action and use thereof
ATE393917T1 (de) Identifikation von therapeutische verbindungen.
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
IT1318691B1 (it) Varianti di proteine allergeniche del gruppo 2 di dermatophagoides.
DE60128445D1 (de) Mutiertes cyclin g1 protein
ATE302008T1 (de) Behandlung von entzündlichen erkrankungen
ECSP013869A (es) Tratamiento del dolor
AR043707A1 (es) Cpmposiciones para el tratamiento de telas y componentes para ello
BR0206918A (pt) Uso de iloperidona
BR0305000A (pt) Novos compostos imidazolidìnicos com atividade esquistossomicida
MY136408A (en) Active substance combinations and therapies for treating abuse of alcohol
FR2812549B1 (fr) Associations dalfopristine/quinupristine avec le cefpirome
ATE456189T1 (de) Spannungsfester mos-schalter